OA11734A - Genes and proteins, and their use. - Google Patents

Genes and proteins, and their use. Download PDF

Info

Publication number: OA11734A
Authority: OA; OAPI
Prior art keywords: pho3; gene; identified; amino acid; homologues
Prior art date: 1998-12-22

Application number

OA1200100163A

Other languages

English (en)

Inventor

Richard James Dobson

Gordon Dougan

Paul Everest

Robert Feldman

Martin John Glenton Hughes

Jonathan Douglas Lane

Joanne Christine Moore

Joseph David Santangelo

Rebecca Kerry Wilson

Original Assignee

Microscience Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-12-22

Filing date

1999-12-22

Publication date

2005-05-12

1998-12-22 Priority claimed from GBGB9828356.7A external-priority patent/GB9828356D0/en

1998-12-22 Priority claimed from GBGB9828359.1A external-priority patent/GB9828359D0/en

1998-12-22 Priority claimed from GBGB9828350.0A external-priority patent/GB9828350D0/en

1998-12-22 Priority claimed from GBGB9828352.6A external-priority patent/GB9828352D0/en

1998-12-22 Priority claimed from GBGB9828357.5A external-priority patent/GB9828357D0/en

1998-12-22 Priority claimed from GBGB9828349.2A external-priority patent/GB9828349D0/en

1998-12-22 Priority claimed from GBGB9828355.9A external-priority patent/GB9828355D0/en

1998-12-22 Priority claimed from GBGB9828353.4A external-priority patent/GB9828353D0/en

1998-12-22 Priority claimed from GBGB9828354.2A external-priority patent/GB9828354D0/en

1998-12-22 Priority claimed from GBGB9828345.0A external-priority patent/GB9828345D0/en

1999-01-04 Priority claimed from GBGB9900085.3A external-priority patent/GB9900085D0/en

1999-01-04 Priority claimed from GBGB9900084.6A external-priority patent/GB9900084D0/en

1999-01-04 Priority claimed from GBGB9900083.8A external-priority patent/GB9900083D0/en

1999-01-04 Priority claimed from GBGB9900086.1A external-priority patent/GB9900086D0/en

1999-01-04 Priority claimed from GBGB9900082.0A external-priority patent/GB9900082D0/en

1999-01-28 Priority claimed from GBGB9901916.8A external-priority patent/GB9901916D0/en

1999-01-28 Priority claimed from GBGB9901922.6A external-priority patent/GB9901922D0/en

1999-12-22 Application filed by Microscience Ltd filed Critical Microscience Ltd

2005-05-12 Publication of OA11734A publication Critical patent/OA11734A/en

Links

108090000623 proteins and genes Proteins 0.000 title abstract description 119
102000004169 proteins and genes Human genes 0.000 title description 17
241000193990 Streptococcus sp. 'group B' Species 0.000 claims abstract description 36
208000015181 infectious disease Diseases 0.000 claims abstract description 14
229960005486 vaccine Drugs 0.000 claims abstract description 13
239000012634 fragment Substances 0.000 claims abstract description 12
239000003814 drug Substances 0.000 claims abstract description 3
125000003275 alpha amino acid group Chemical group 0.000 claims description 33
108090000765 processed proteins & peptides Proteins 0.000 claims description 24
208000035357 Focal Infection Diseases 0.000 claims description 3
238000004519 manufacturing process Methods 0.000 claims description 3
238000012216 screening Methods 0.000 claims description 3
230000001225 therapeutic effect Effects 0.000 claims description 3
208000019206 urinary tract infection Diseases 0.000 claims description 3
229940079593 drug Drugs 0.000 claims description 2
230000001018 virulence Effects 0.000 claims description 2
206010061372 Streptococcal infection Diseases 0.000 claims 1
102000040430 polynucleotide Human genes 0.000 claims 1
108091033319 polynucleotide Proteins 0.000 claims 1
239000002157 polynucleotide Substances 0.000 claims 1
230000000813 microbial effect Effects 0.000 abstract 1
239000013612 plasmid Substances 0.000 description 27
101150009573 phoA gene Proteins 0.000 description 26
241000193996 Streptococcus pyogenes Species 0.000 description 25
101100084022 Pseudomonas aeruginosa (strain ATCC 15692 / DSM 22644 / CIP 104116 / JCM 14847 / LMG 12228 / 1C / PRS 101 / PAO1) lapA gene Proteins 0.000 description 18
241000588724 Escherichia coli Species 0.000 description 11
102000004196 processed proteins & peptides Human genes 0.000 description 10
241000194032 Enterococcus faecalis Species 0.000 description 9
210000004027 cell Anatomy 0.000 description 9
235000014469 Bacillus subtilis Nutrition 0.000 description 7
241000194019 Streptococcus mutans Species 0.000 description 7
230000001580 bacterial effect Effects 0.000 description 7
229940032049 enterococcus faecalis Drugs 0.000 description 7
102000002260 Alkaline Phosphatase Human genes 0.000 description 6
108020004774 Alkaline Phosphatase Proteins 0.000 description 6
108020004414 DNA Proteins 0.000 description 6
241000193998 Streptococcus pneumoniae Species 0.000 description 6
101150015333 kup gene Proteins 0.000 description 6
229940031000 streptococcus pneumoniae Drugs 0.000 description 6
241000894006 Bacteria Species 0.000 description 5
101150081160 dltB gene Proteins 0.000 description 5
101150012056 OPRL1 gene Proteins 0.000 description 4
108700020474 Penicillin-Binding Proteins Proteins 0.000 description 4
229940023064 escherichia coli Drugs 0.000 description 4
238000002649 immunization Methods 0.000 description 4
238000002560 therapeutic procedure Methods 0.000 description 4
239000013598 vector Substances 0.000 description 4
244000063299 Bacillus subtilis Species 0.000 description 3
108010078791 Carrier Proteins Proteins 0.000 description 3
108090000860 Endopeptidase Clp Proteins 0.000 description 3
102000004190 Enzymes Human genes 0.000 description 3
108090000790 Enzymes Proteins 0.000 description 3
241001465754 Metazoa Species 0.000 description 3
206010040047 Sepsis Diseases 0.000 description 3
150000001413 amino acids Chemical class 0.000 description 3
210000002421 cell wall Anatomy 0.000 description 3
230000000694 effects Effects 0.000 description 3
229940088598 enzyme Drugs 0.000 description 3
239000013615 primer Substances 0.000 description 3
108091008146 restriction endonucleases Proteins 0.000 description 3
239000000758 substrate Substances 0.000 description 3
241000589969 Borreliella burgdorferi Species 0.000 description 2
241000283690 Bos taurus Species 0.000 description 2
241000193764 Brevibacillus brevis Species 0.000 description 2
102000014914 Carrier Proteins Human genes 0.000 description 2
108020004705 Codon Proteins 0.000 description 2
241000606768 Haemophilus influenzae Species 0.000 description 2
101100077927 Haemophilus influenzae (strain ATCC 51907 / DSM 11121 / KW20 / Rd) mrdA gene Proteins 0.000 description 2
244000199866 Lactobacillus casei Species 0.000 description 2
241000186840 Lactobacillus fermentum Species 0.000 description 2
108090001030 Lipoproteins Proteins 0.000 description 2
102000004895 Lipoproteins Human genes 0.000 description 2
101710084556 Low affinity potassium transport system protein kup Proteins 0.000 description 2
101710183187 Major outer membrane lipoprotein Proteins 0.000 description 2
108010052285 Membrane Proteins Proteins 0.000 description 2
102000018697 Membrane Proteins Human genes 0.000 description 2
241000699670 Mus sp. Species 0.000 description 2
NVNLLIYOARQCIX-MSHCCFNRSA-N Nisin Chemical compound N1C(=O)[C@@H](CC(C)C)NC(=O)C(=C)NC(=O)[C@@H]([C@H](C)CC)NC(=O)[C@@H](NC(=O)C(=C/C)/NC(=O)[C@H](N)[C@H](C)CC)CSC[C@@H]1C(=O)N[C@@H]1C(=O)N2CCC[C@@H]2C(=O)NCC(=O)N[C@@H](C(=O)N[C@H](CCCCN)C(=O)N[C@@H]2C(NCC(=O)N[C@H](C)C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCSC)C(=O)NCC(=O)N[C@H](CS[C@@H]2C)C(=O)N[C@H](CC(N)=O)C(=O)N[C@H](CCSC)C(=O)N[C@H](CCCCN)C(=O)N[C@@H]2C(N[C@H](C)C(=O)N[C@@H]3C(=O)N[C@@H](C(N[C@H](CC=4NC=NC=4)C(=O)N[C@H](CS[C@@H]3C)C(=O)N[C@H](CO)C(=O)N[C@H]([C@H](C)CC)C(=O)N[C@H](CC=3NC=NC=3)C(=O)N[C@H](C(C)C)C(=O)NC(=C)C(=O)N[C@H](CCCCN)C(O)=O)=O)CS[C@@H]2C)=O)=O)CS[C@@H]1C NVNLLIYOARQCIX-MSHCCFNRSA-N 0.000 description 2
108010053775 Nisin Proteins 0.000 description 2
241000283973 Oryctolagus cuniculus Species 0.000 description 2
ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 2
102000007056 Recombinant Fusion Proteins Human genes 0.000 description 2
108010008281 Recombinant Fusion Proteins Proteins 0.000 description 2
101100054091 Schizosaccharomyces pombe (strain 972 / ATCC 24843) par2 gene Proteins 0.000 description 2
241000607762 Shigella flexneri Species 0.000 description 2
241000191965 Staphylococcus carnosus Species 0.000 description 2
241000264435 Streptococcus dysgalactiae subsp. equisimilis Species 0.000 description 2
241000607477 Yersinia pseudotuberculosis Species 0.000 description 2
206010000269 abscess Diseases 0.000 description 2
239000000427 antigen Substances 0.000 description 2
108091007433 antigens Proteins 0.000 description 2
102000036639 antigens Human genes 0.000 description 2
238000010367 cloning Methods 0.000 description 2
230000001419 dependent effect Effects 0.000 description 2
238000010790 dilution Methods 0.000 description 2
239000012895 dilution Substances 0.000 description 2
108010060371 endo-N-acetylmuramidase Proteins 0.000 description 2
229940047650 haemophilus influenzae Drugs 0.000 description 2
238000011534 incubation Methods 0.000 description 2
230000009545 invasion Effects 0.000 description 2
101150109648 lppC gene Proteins 0.000 description 2
208000004396 mastitis Diseases 0.000 description 2
238000000034 method Methods 0.000 description 2
239000004309 nisin Substances 0.000 description 2
235000010297 nisin Nutrition 0.000 description 2
101150055083 ospC gene Proteins 0.000 description 2
101150053585 perM gene Proteins 0.000 description 2
230000004260 plant-type cell wall biogenesis Effects 0.000 description 2
229910052700 potassium Inorganic materials 0.000 description 2
239000011591 potassium Substances 0.000 description 2
239000002243 precursor Substances 0.000 description 2
101150044856 spaR gene Proteins 0.000 description 2
238000011144 upstream manufacturing Methods 0.000 description 2
QRXMUCSWCMTJGU-UHFFFAOYSA-L (5-bromo-4-chloro-1h-indol-3-yl) phosphate Chemical compound C1=C(Br)C(Cl)=C2C(OP([O-])(=O)[O-])=CNC2=C1 QRXMUCSWCMTJGU-UHFFFAOYSA-L 0.000 description 1
FKJSFKCZZIXQIP-UHFFFAOYSA-N 2-bromo-1-(4-bromophenyl)ethanone Chemical compound BrCC(=O)C1=CC=C(Br)C=C1 FKJSFKCZZIXQIP-UHFFFAOYSA-N 0.000 description 1
101710088758 23kDa protein Proteins 0.000 description 1
XZKIHKMTEMTJQX-UHFFFAOYSA-N 4-Nitrophenyl Phosphate Chemical compound OP(O)(=O)OC1=CC=C([N+]([O-])=O)C=C1 XZKIHKMTEMTJQX-UHFFFAOYSA-N 0.000 description 1
ITZMJCSORYKOSI-AJNGGQMLSA-N APGPR Enterostatin Chemical compound C[C@H](N)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N1[C@H](C(=O)N[C@@H](CCCN=C(N)N)C(O)=O)CCC1 ITZMJCSORYKOSI-AJNGGQMLSA-N 0.000 description 1
102000005416 ATP-Binding Cassette Transporters Human genes 0.000 description 1
108010006533 ATP-Binding Cassette Transporters Proteins 0.000 description 1
229920001817 Agar Polymers 0.000 description 1
241000893512 Aquifex aeolicus Species 0.000 description 1
101100455969 Bacillus subtilis (strain 168) mdxK gene Proteins 0.000 description 1
101100268003 Bacillus subtilis (strain 168) yutD gene Proteins 0.000 description 1
101710166119 Basic membrane protein Proteins 0.000 description 1
241000589968 Borrelia Species 0.000 description 1
241001467572 Brevibacterium casei Species 0.000 description 1
108091035707 Consensus sequence Proteins 0.000 description 1
125000000030 D-alanine group Chemical class [H]N([H])[C@](C([H])([H])[H])(C(=O)[*])[H] 0.000 description 1
SHZGCJCMOBCMKK-UHFFFAOYSA-N D-mannomethylose Natural products CC1OC(O)C(O)C(O)C1O SHZGCJCMOBCMKK-UHFFFAOYSA-N 0.000 description 1
239000003155 DNA primer Substances 0.000 description 1
241000238557 Decapoda Species 0.000 description 1
244000024708 Dioscorea cayenensis Species 0.000 description 1
238000002965 ELISA Methods 0.000 description 1
241000194033 Enterococcus Species 0.000 description 1
101100053968 Escherichia coli (strain K12) znuC gene Proteins 0.000 description 1
101100173396 Haemophilus influenzae (strain ATCC 51907 / DSM 11121 / KW20 / Rd) fbpC1 gene Proteins 0.000 description 1
206010053317 Hydrophobia Diseases 0.000 description 1
206010061598 Immunodeficiency Diseases 0.000 description 1
102000017727 Immunoglobulin Variable Region Human genes 0.000 description 1
108010067060 Immunoglobulin Variable Region Proteins 0.000 description 1
108090000862 Ion Channels Proteins 0.000 description 1
102000004310 Ion Channels Human genes 0.000 description 1
SHZGCJCMOBCMKK-JFNONXLTSA-N L-rhamnopyranose Chemical compound C[C@@H]1OC(O)[C@H](O)[C@H](O)[C@H]1O SHZGCJCMOBCMKK-JFNONXLTSA-N 0.000 description 1
PNNNRSAQSRJVSB-UHFFFAOYSA-N L-rhamnose Natural products CC(O)C(O)C(O)C(O)C=O PNNNRSAQSRJVSB-UHFFFAOYSA-N 0.000 description 1
235000013958 Lactobacillus casei Nutrition 0.000 description 1
241000186606 Lactobacillus gasseri Species 0.000 description 1
241000186604 Lactobacillus reuteri Species 0.000 description 1
241001625930 Luria Species 0.000 description 1
208000016604 Lyme disease Diseases 0.000 description 1
FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
102000003939 Membrane transport proteins Human genes 0.000 description 1
108090000301 Membrane transport proteins Proteins 0.000 description 1
201000009906 Meningitis Diseases 0.000 description 1
241000186362 Mycobacterium leprae Species 0.000 description 1
108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 description 1
108091028043 Nucleic acid sequence Proteins 0.000 description 1
101710116435 Outer membrane protein Proteins 0.000 description 1
102000004316 Oxidoreductases Human genes 0.000 description 1
108090000854 Oxidoreductases Proteins 0.000 description 1
108091000080 Phosphotransferase Proteins 0.000 description 1
206010035664 Pneumonia Diseases 0.000 description 1
108010076504 Protein Sorting Signals Proteins 0.000 description 1
241000589517 Pseudomonas aeruginosa Species 0.000 description 1
241000589540 Pseudomonas fluorescens Species 0.000 description 1
240000004808 Saccharomyces cerevisiae Species 0.000 description 1
241000607142 Salmonella Species 0.000 description 1
241001123650 Schwanniomyces occidentalis Species 0.000 description 1
102100027287 Serpin H1 Human genes 0.000 description 1
108050008290 Serpin H1 Proteins 0.000 description 1
241000191967 Staphylococcus aureus Species 0.000 description 1
108091081024 Start codon Proteins 0.000 description 1
241000194017 Streptococcus Species 0.000 description 1
244000057717 Streptococcus lactis Species 0.000 description 1
235000014897 Streptococcus lactis Nutrition 0.000 description 1
241000194024 Streptococcus salivarius Species 0.000 description 1
241000194021 Streptococcus suis Species 0.000 description 1
241000194020 Streptococcus thermophilus Species 0.000 description 1
CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
229930006000 Sucrose Natural products 0.000 description 1
241000607447 Yersinia enterocolitica Species 0.000 description 1
239000002253 acid Substances 0.000 description 1
239000002671 adjuvant Substances 0.000 description 1
239000008272 agar Substances 0.000 description 1
229940037003 alum Drugs 0.000 description 1
230000003321 amplification Effects 0.000 description 1
238000004458 analytical method Methods 0.000 description 1
239000003242 anti bacterial agent Substances 0.000 description 1
229940088710 antibiotic agent Drugs 0.000 description 1
239000011324 bead Substances 0.000 description 1
238000010009 beating Methods 0.000 description 1
108091008324 binding proteins Proteins 0.000 description 1
230000003115 biocidal effect Effects 0.000 description 1
230000015572 biosynthetic process Effects 0.000 description 1
239000001055 blue pigment Substances 0.000 description 1
239000000969 carrier Substances 0.000 description 1
230000003197 catalytic effect Effects 0.000 description 1
210000000170 cell membrane Anatomy 0.000 description 1
238000005119 centrifugation Methods 0.000 description 1
238000006243 chemical reaction Methods 0.000 description 1
239000003795 chemical substances by application Substances 0.000 description 1
239000013611 chromosomal DNA Substances 0.000 description 1
210000000349 chromosome Anatomy 0.000 description 1
239000013599 cloning vector Substances 0.000 description 1
238000012790 confirmation Methods 0.000 description 1
102000004432 dTDP-4-dehydrorhamnose reductase Human genes 0.000 description 1
108010083506 dTDP-4-dehydrorhamnose reductase Proteins 0.000 description 1
ZOSQFDVXNQFKBY-ZORVDHEWSA-N dTDP-rhamnose Chemical compound OC1C(O)C(O)C(C)OC1OP(O)(=O)OP(O)(=O)OC[C@@H]1[C@@H](O)C[C@H](N2C(NC(=O)C(C)=C2)=O)O1 ZOSQFDVXNQFKBY-ZORVDHEWSA-N 0.000 description 1
KAKKHKRHCKCAGH-UHFFFAOYSA-L disodium;(4-nitrophenyl) phosphate;hexahydrate Chemical compound O.O.O.O.O.O.[Na+].[Na+].[O-][N+](=O)C1=CC=C(OP([O-])([O-])=O)C=C1 KAKKHKRHCKCAGH-UHFFFAOYSA-L 0.000 description 1
238000002474 experimental method Methods 0.000 description 1
101150020570 fbpC gene Proteins 0.000 description 1
101150005487 ftsI gene Proteins 0.000 description 1
238000001415 gene therapy Methods 0.000 description 1
150000004676 glycans Chemical class 0.000 description 1
230000028993 immune response Effects 0.000 description 1
230000002163 immunogen Effects 0.000 description 1
238000001727 in vivo Methods 0.000 description 1
230000001939 inductive effect Effects 0.000 description 1
229960004717 insulin aspart Drugs 0.000 description 1
238000007912 intraperitoneal administration Methods 0.000 description 1
229940017800 lactobacillus casei Drugs 0.000 description 1
229940012969 lactobacillus fermentum Drugs 0.000 description 1
101150080142 lpoA gene Proteins 0.000 description 1
229920002521 macromolecule Polymers 0.000 description 1
101150003248 malK gene Proteins 0.000 description 1
239000003550 marker Substances 0.000 description 1
239000012528 membrane Substances 0.000 description 1
244000005700 microbiome Species 0.000 description 1
239000008267 milk Substances 0.000 description 1
235000013336 milk Nutrition 0.000 description 1
210000004080 milk Anatomy 0.000 description 1
239000000203 mixture Substances 0.000 description 1
101150064202 mrdA gene Proteins 0.000 description 1
238000011587 new zealand white rabbit Methods 0.000 description 1
VOMXSOIBEJBQNF-UTTRGDHVSA-N novorapid Chemical compound C([C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CS)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@H](CO)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CS)NC(=O)[C@H](CS)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@@H](NC(=O)CN)[C@@H](C)CC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(O)=O)C1=CC=C(O)C=C1.C([C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CS)C(=O)NCC(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(O)=O)C(C)C)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CS)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=1NC=NC=1)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)CC=1C=CC=CC=1)C(C)C)C1=CN=CN1 VOMXSOIBEJBQNF-UTTRGDHVSA-N 0.000 description 1
238000003199 nucleic acid amplification method Methods 0.000 description 1
101150005569 pbpA gene Proteins 0.000 description 1
101150060462 pbpB gene Proteins 0.000 description 1
101150028051 pbpC gene Proteins 0.000 description 1
239000000546 pharmaceutical excipient Substances 0.000 description 1
102000020233 phosphotransferase Human genes 0.000 description 1
239000013600 plasmid vector Substances 0.000 description 1
229920001282 polysaccharide Polymers 0.000 description 1
239000005017 polysaccharide Substances 0.000 description 1
101150016899 potA gene Proteins 0.000 description 1
230000035935 pregnancy Effects 0.000 description 1
125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
230000001737 promoting effect Effects 0.000 description 1
230000000644 propagated effect Effects 0.000 description 1
230000000069 prophylactic effect Effects 0.000 description 1
230000007065 protein hydrolysis Effects 0.000 description 1
230000002797 proteolythic effect Effects 0.000 description 1
108020003175 receptors Proteins 0.000 description 1
238000010188 recombinant method Methods 0.000 description 1
230000004044 response Effects 0.000 description 1
238000012163 sequencing technique Methods 0.000 description 1
230000035939 shock Effects 0.000 description 1
238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 1
239000005720 sucrose Substances 0.000 description 1
239000002344 surface layer Substances 0.000 description 1
230000004083 survival effect Effects 0.000 description 1
230000009466 transformation Effects 0.000 description 1
238000013519 translation Methods 0.000 description 1
210000004291 uterus Anatomy 0.000 description 1
238000001262 western blot Methods 0.000 description 1
229940098232 yersinia enterocolitica Drugs 0.000 description 1

Classifications

- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
- A61K39/092—Streptococcus
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56911—Bacteria
- G01N33/56944—Streptococcus
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Engineering & Computer Science (AREA)
Immunology (AREA)
Organic Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Molecular Biology (AREA)
Microbiology (AREA)
Biomedical Technology (AREA)
Genetics & Genomics (AREA)
Bioinformatics & Cheminformatics (AREA)
Mycology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Urology & Nephrology (AREA)
Epidemiology (AREA)
Biochemistry (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Hematology (AREA)
Biotechnology (AREA)
Physics & Mathematics (AREA)
Biophysics (AREA)
General Engineering & Computer Science (AREA)
General Physics & Mathematics (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Gastroenterology & Hepatology (AREA)
Tropical Medicine & Parasitology (AREA)
Virology (AREA)
Zoology (AREA)
Physical Education & Sports Medicine (AREA)
Cell Biology (AREA)
Wood Science & Technology (AREA)
Food Science & Technology (AREA)
Pathology (AREA)

OA1200100163A 1998-12-22 1999-12-22 Genes and proteins, and their use. OA11734A (en)

Applications Claiming Priority (17)

Application Number	Priority Date	Filing Date	Title
GBGB9828350.0A GB9828350D0 (en)	1998-12-22	1998-12-22	Protein and compositions containing it
GBGB9828345.0A GB9828345D0 (en)	1998-12-22	1998-12-22	Protein and compositions containing it
GBGB9828357.5A GB9828357D0 (en)	1998-12-22	1998-12-22	Protein and compositions containing it
GBGB9828349.2A GB9828349D0 (en)	1998-12-22	1998-12-22	Protein and compositions containing it
GBGB9828355.9A GB9828355D0 (en)	1998-12-22	1998-12-22	Protein and compositions containing it
GBGB9828353.4A GB9828353D0 (en)	1998-12-22	1998-12-22	Protein and compositions containig it
GBGB9828356.7A GB9828356D0 (en)	1998-12-22	1998-12-22	Protein and compositions containing it
GBGB9828352.6A GB9828352D0 (en)	1998-12-22	1998-12-22	Protein and compositions containing it
GBGB9828359.1A GB9828359D0 (en)	1998-12-22	1998-12-22	Protein and compositions containing it
GBGB9828354.2A GB9828354D0 (en)	1998-12-22	1998-12-22	Protein and compositions containing it
GBGB9900085.3A GB9900085D0 (en)	1999-01-04	1999-01-04	Protein and compositions containing it
GBGB9900084.6A GB9900084D0 (en)	1999-01-04	1999-01-04	Protein and compositions containing it
GBGB9900083.8A GB9900083D0 (en)	1999-01-04	1999-01-04	Protein and compositions containing it
GBGB9900086.1A GB9900086D0 (en)	1999-01-04	1999-01-04	Protein and compositions containing it
GBGB9900082.0A GB9900082D0 (en)	1999-01-04	1999-01-04	Protein and compositions containing it
GBGB9901916.8A GB9901916D0 (en)	1999-01-28	1999-01-28	Protein and compositions containing it
GBGB9901922.6A GB9901922D0 (en)	1999-01-28	1999-01-28	Protein and compositions containing it

Publications (1)

Publication Number	Publication Date
OA11734A true OA11734A (en)	2005-05-12

Family

ID=27585888

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
OA1200100163A OA11734A (en)	1998-12-22	1999-12-22	Genes and proteins, and their use.

Country Status (22)

Country	Link
US (3)	US6812021B1 (de)
EP (3)	EP2105504A3 (de)
JP (1)	JP2002533083A (de)
KR (3)	KR100790653B1 (de)
CN (1)	CN101066447A (de)
AP (1)	AP1502A (de)
AT (1)	ATE353367T1 (de)
AU (1)	AU776735B2 (de)
CA (1)	CA2354135A1 (de)
CY (1)	CY1106559T1 (de)
CZ (1)	CZ20012172A3 (de)
DK (1)	DK1141308T3 (de)
EA (1)	EA004444B1 (de)
ES (1)	ES2281977T3 (de)
HU (1)	HUP0104825A3 (de)
NO (1)	NO20013102L (de)
NZ (3)	NZ512297A (de)
OA (1)	OA11734A (de)
PL (1)	PL201887B1 (de)
PT (1)	PT1141308E (de)
SI (1)	SI1141308T1 (de)
WO (1)	WO2000037646A2 (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6890539B2 (en)	1998-12-22	2005-05-10	Microscience, Ltd.	Genes and proteins, and their use
SI1140994T1 (sl) *	1998-12-22	2005-12-31	Microscience Ltd	Proteini zunanje povrsine, njihovi geni in njihova uporaba
US6812021B1 (en) *	1998-12-22	2004-11-02	Microscience Limited	Genes and proteins and their use
GB0105922D0 (en) *	2001-03-09	2001-04-25	Microscience Ltd	Genes and proteins, and their use
EP1360324A2 (de)	2000-08-31	2003-11-12	Mayo Foundation For Medical Education And Research	Nachweis von varicella-zoster-virus
GB0021977D0 (en)	2000-09-07	2000-10-25	Pyrosequencing Ab	Method of sequencing DNA
US7691571B2 (en)	2001-01-31	2010-04-06	Mayo Foundation For Medical Education And Research	Detection of bordetella
US7074598B2 (en)	2002-09-25	2006-07-11	Mayo Foundation For Medical Education And Research	Detection of vancomycin-resistant enterococcus spp.
US7365176B2 (en)	2002-09-26	2008-04-29	Mayo Foundation For Medical Education And Research	Detection of Epstein-Barr virus
CA2507711A1 (en) *	2002-12-02	2004-06-17	Biosynexus Incorporated	Wall teichoic acid as a target for anti-staphylococcal therapies and vaccines
US7427475B2 (en) *	2003-11-18	2008-09-23	Mayo Foundation For Medical Education And Research	Detection of group B streptococcus
EP2104512A2 (de) *	2006-12-21	2009-09-30	Emergent Product Development UK Limited	Streptokokkenproteine und deren verwendung bei der impfung
US10114982B2 (en)	2012-05-18	2018-10-30	Tata Consultancy Services Limited	Method and system for determining and implementing a viable containment design of a data center
CN106822885B (zh)	2017-02-16	2020-06-30	清华大学	肺炎链球菌疫苗

Family Cites Families (38)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5328996A (en)	1989-03-29	1994-07-12	University Of Florida Research Foundation, Inc.	Bacterial plasmin receptors as fibrinolytic agents
CA2127550A1 (en)	1992-01-08	1993-07-22	Vincent Fischetti	Multifunctional surface protein of streptococci
WO1994021685A1 (en) *	1993-03-19	1994-09-29	Gunnar Lindahl	Protein rib, a cell surface protein that confers immunity to many strains of the group b streptococcus; process for purification of the protein, reagent kit and pharmaceutical composition
US6015889A (en)	1993-03-19	2000-01-18	Gunnar Lindahl	Protein rib, a cell surface protein that confers immunity to many strains of the group B streptococcus: process for purification of the protein, reagent kit and pharmaceutical composition
US5807978A (en) *	1995-06-07	1998-09-15	Kokolus; William J.	Immunogenic peptides of prostate specific antigen
PT942983E (pt)	1996-10-31	2007-02-28	Human Genome Sciences Inc	Antigénios e vacinas de streptococcus pneumoniae
US7196164B2 (en)	1997-07-08	2007-03-27	Human Genome Sciences, Inc.	Secreted protein HHTLF25
US6800744B1 (en)	1997-07-02	2004-10-05	Genome Therapeutics Corporation	Nucleic acid and amino acid sequences relating to Streptococcus pneumoniae for diagnostics and therapeutics
US7081530B1 (en) *	1997-07-02	2006-07-25	sanofi pasteur limitée	Nucleic acid and amino acid sequences relating to Streptococcus pneumoniae for diagnostics and therapeutics
US6380370B1 (en)	1997-08-14	2002-04-30	Genome Therapeutics Corporation	Nucleic acid and amino acid sequences relating to Staphylococcus epidermidis for diagnostics and therapeutics
WO1999042588A2 (en)	1998-02-20	1999-08-26	Biochem Pharma Inc.	Group b streptococcus antigens
US6248329B1 (en) *	1998-06-01	2001-06-19	Ramaswamy Chandrashekar	Parasitic helminth cuticlin nucleic acid molecules and uses thereof
CN1247262C (zh)	1998-07-14	2006-03-29	惠氏控股有限公司	含有单磷酸脂a的佐剂和疫苗组合物
CA2337102A1 (en) *	1998-07-27	2000-02-10	Richard William Falla Le Page	Nucleic acids and proteins from group b streptococcus
NZ511224A (en)	1998-10-30	2003-10-31	Janssen Pharmaceutica Nv	The use of the pCal retrotransposon in methods of gene disruption or altered expression in yeast or fungus
AU1818200A (en)	1998-11-05	2000-05-22	Daniel Carucci	Chromosome 2 sequence of the human malaria parasite (plasmodium falciparum) and proteins of said chromosome useful in anti-malarial vaccines and diagnostic reagents
US6890539B2 (en)	1998-12-22	2005-05-10	Microscience, Ltd.	Genes and proteins, and their use
US6812021B1 (en)	1998-12-22	2004-11-02	Microscience Limited	Genes and proteins and their use
SI1140994T1 (sl)	1998-12-22	2005-12-31	Microscience Ltd	Proteini zunanje povrsine, njihovi geni in njihova uporaba
WO2000061621A2 (en)	1999-04-09	2000-10-19	Heska Corporation	Flea head, nerve cord, hindgut and malpighian tubule nucleic acid molecules, proteins and uses thereof
US6605709B1 (en)	1999-04-09	2003-08-12	Genome Therapeutics Corporation	Nucleic acid and amino acid sequences relating to Proteus mirabilis for diagnostics and therapeutics
GB9921125D0 (en)	1999-09-07	1999-11-10	Microbial Technics Limited	Proteins
AU1478301A (en)	1999-11-09	2001-06-06	Glaxo Group Limited	Staphylococcus epidermidis nucleic acids and proteins
JP2004507217A (ja)	2000-04-11	2004-03-11	アンスティテュ・パストゥール	リステリア菌ゲノム、ポリペプチドおよびその使用
US6974667B2 (en)	2000-06-14	2005-12-13	Gene Logic, Inc.	Gene expression profiles in liver cancer
US7939087B2 (en)	2000-10-27	2011-05-10	Novartis Vaccines And Diagnostics, Inc.	Nucleic acids and proteins from Streptococcus groups A & B
WO2002077183A2 (en)	2001-03-21	2002-10-03	Elitra Pharmaceuticals, Inc.	Identification of essential genes in microorganisms
GB0107661D0 (en)	2001-03-27	2001-05-16	Chiron Spa	Staphylococcus aureus
GB0107658D0 (en)	2001-03-27	2001-05-16	Chiron Spa	Streptococcus pneumoniae
MXPA03009415A (es)	2001-04-16	2004-01-29	Wyeth Corp	ESTRUCTURAS NOVEDOSAS DE LECTURA ABIERTA DE STREPTOCOCCUS PNEUMONIAE QUE CODIFICAN ANTIGENOS DE POLIPePTIDOS Y USOS DE LAS MISMAS.
EP2545937A1 (de)	2001-06-05	2013-01-16	The Regents Of The University Of Michigan	Nanoemulsionsimpfstoffe
WO2003009869A1 (en)	2001-07-26	2003-02-06	Chiron Srl.	Vaccines comprising aluminium adjuvants and histidine
GB0210128D0 (en)	2002-05-02	2002-06-12	Chiron Spa	Nucleic acids and proteins from streptococcus groups A & B
WO2004041157A2 (en)	2002-09-13	2004-05-21	Chiron Corporation	Group b streptococcus vaccine
CN101864431A (zh)	2003-05-07	2010-10-20	英特塞尔股份公司	无乳链球菌抗原ⅰ和ⅱ
EP1663303B1 (de)	2003-09-15	2011-05-04	Novartis Vaccines and Diagnostics, Inc.	Immunogene zusammensetzungen für streptococcus agalactiae
AU2005335216A1 (en)	2004-10-05	2007-02-15	Wyeth	Probe arrays for detecting multiple strains of different species
AU2005319174A1 (en)	2004-12-22	2006-06-29	J. Craig Venter Institute, Inc.	Group B Streptococcus

1999
- 1999-12-22 US US09/868,352 patent/US6812021B1/en not_active Expired - Fee Related
- 1999-12-22 SI SI9930959T patent/SI1141308T1/sl unknown
- 1999-12-22 ES ES99962422T patent/ES2281977T3/es not_active Expired - Lifetime
- 1999-12-22 CN CNA2007101018407A patent/CN101066447A/zh active Pending
- 1999-12-22 CZ CZ20012172A patent/CZ20012172A3/cs unknown
- 1999-12-22 DK DK99962422T patent/DK1141308T3/da active
- 1999-12-22 CA CA002354135A patent/CA2354135A1/en not_active Abandoned
- 1999-12-22 EA EA200100700A patent/EA004444B1/ru not_active IP Right Cessation
- 1999-12-22 HU HU0104825A patent/HUP0104825A3/hu unknown
- 1999-12-22 AU AU18780/00A patent/AU776735B2/en not_active Ceased
- 1999-12-22 AT AT99962422T patent/ATE353367T1/de not_active IP Right Cessation
- 1999-12-22 EP EP09159100A patent/EP2105504A3/de not_active Withdrawn
- 1999-12-22 OA OA1200100163A patent/OA11734A/en unknown
- 1999-12-22 WO PCT/GB1999/004377 patent/WO2000037646A2/en not_active Ceased
- 1999-12-22 EP EP99962422A patent/EP1141308B1/de not_active Expired - Lifetime
- 1999-12-22 NZ NZ512297A patent/NZ512297A/en unknown
- 1999-12-22 NZ NZ535122A patent/NZ535122A/en unknown
- 1999-12-22 JP JP2000589700A patent/JP2002533083A/ja active Pending
- 1999-12-22 PT PT99962422T patent/PT1141308E/pt unknown
- 1999-12-22 EP EP06019847A patent/EP1757696A3/de not_active Withdrawn
- 1999-12-22 PL PL349320A patent/PL201887B1/pl not_active IP Right Cessation
- 1999-12-22 KR KR1020017007911A patent/KR100790653B1/ko not_active Expired - Fee Related
- 1999-12-22 AP APAP/P/2001/002189A patent/AP1502A/en active
- 1999-12-22 NZ NZ526879A patent/NZ526879A/xx unknown
2001
- 2001-06-21 NO NO20013102A patent/NO20013102L/no not_active Application Discontinuation
2004
- 2004-03-12 US US10/799,072 patent/US7419672B2/en not_active Expired - Fee Related
2007
- 2007-05-04 CY CY20071100589T patent/CY1106559T1/el unknown
- 2007-08-17 US US11/892,024 patent/US20090274717A1/en not_active Abandoned
- 2007-09-28 KR KR1020070098153A patent/KR20070101197A/ko not_active Ceased
2008
- 2008-05-09 KR KR1020080043336A patent/KR20080050550A/ko not_active Ceased

Also Published As

Publication number	Publication date
US20080181908A1 (en)	2008-07-31
ES2281977T3 (es)	2007-10-01
SI1141308T1 (sl)	2007-08-31
HUP0104825A2 (hu)	2002-04-29
CZ20012172A3 (cs)	2001-11-14
AP1502A (en)	2005-12-20
KR20080050550A (ko)	2008-06-09
EP1757696A2 (de)	2007-02-28
NZ512297A (en)	2003-12-19
HK1039353A1 (en)	2002-04-19
PL201887B1 (pl)	2009-05-29
PL349320A1 (en)	2002-07-15
EP2105504A3 (de)	2010-01-06
AU1878000A (en)	2000-07-12
US7419672B2 (en)	2008-09-02
AU776735B2 (en)	2004-09-23
NO20013102D0 (no)	2001-06-21
KR20070101197A (ko)	2007-10-16
KR20010089844A (ko)	2001-10-11
EP2105504A2 (de)	2009-09-30
US6812021B1 (en)	2004-11-02
WO2000037646A2 (en)	2000-06-29
JP2002533083A (ja)	2002-10-08
CY1106559T1 (el)	2012-01-25
NZ526879A (en)	2004-12-24
ATE353367T1 (de)	2007-02-15
AP2001002189A0 (en)	2001-06-30
DK1141308T3 (da)	2007-06-04
US20090274717A1 (en)	2009-11-05
CN101066447A (zh)	2007-11-07
PT1141308E (pt)	2007-05-31
EP1141308A2 (de)	2001-10-10
HUP0104825A3 (en)	2008-04-28
NO20013102L (no)	2001-08-10
EP1757696A3 (de)	2008-10-29
CA2354135A1 (en)	2000-06-29
EP1141308B1 (de)	2007-02-07
EA200100700A1 (ru)	2001-12-24
WO2000037646A3 (en)	2000-10-26
EA004444B1 (ru)	2004-04-29
NZ535122A (en)	2006-04-28
KR100790653B1 (ko)	2007-12-31

Publication	Publication Date	Title
US20090274717A1 (en)	2009-11-05	Genes and proteins, and their use
JP5051959B2 (ja)	2012-10-17	ストレプトコッカス抗原
US20080226641A1 (en)	2008-09-18	Outer surface proteins, their genes, and their use
US6890539B2 (en)	2005-05-10	Genes and proteins, and their use
AU2004201404B2 (en)	2007-01-25	Genes and proteins, and their use
EP1366068A1 (de)	2003-12-03	Polynucleotide and polypeptide aus gruppe-b streptococcus und ihre verwendung zur herstellung eines impfstoffs
NZ543923A (en)	2008-07-31	Pho3-18 for a theraputic use, particulary in bacterial infection.
ZA200104818B (en)	2002-06-13	Genes and proteins, and their use.
AU2007200004A1 (en)	2007-02-01	Genes and proteins, and their use
HK1039353B (en)	2007-07-13	Group b streptococcus proteins, and their use
PL195869B1 (pl)	2007-11-30	Peptyd, szczepionka, zastosowanie tego peptydu i przeciwciało
HK1083029A (en)	2006-06-23	Outer surface proteins, their genes, and their use
HK1039339B (en)	2005-10-14	Outer surface proteins, their genes, and their use